Study on optimal extemporaneous compounding method for pediatric use of captopril
碩士 === 國立臺灣大學 === 臨床藥學研究所 === 90 === Captopril, an angiotensin converting enzyme inhibitor, is often used to treat hypertension and congestive heart failure in pediatric patients. Because there is no suitable dosage form of captopril for pediatric use, providing compounding service for di...
Main Authors: | WanYun Liu, 劉宛昀 |
---|---|
Other Authors: | ChurnShiouh Gau |
Format: | Others |
Language: | zh-TW |
Published: |
2002
|
Online Access: | http://ndltd.ncl.edu.tw/handle/51700270661064261859 |
Similar Items
-
Stability of Extemporaneously Prepared Captopril Solution
by: Park, Sean, et al.
Published: (2012) -
The Extent of Extemporaneous Preparation and Regulatory Framework of Extemporaneous Compounding in Latvia
by: Olga Kiseļova, et al.
Published: (2019-08-01) -
Use of compounded dispersing media for extemporaneous pediatric syrups with candesartan cilexetil and valsartan
by: Musko Monika, et al.
Published: (2014-12-01) -
Extemporaneous Compounding: Cautions, Controversies and Convenience
by: AK Mohiuddin
Published: (2019-01-01) -
Stability of extemporaneously compounded amiloride nasal spray.
by: Venkata Yellepeddi, et al.
Published: (2020-01-01)